[unable to retrieve full-text content]

Aduhelm, the recently approved medicine to treat Alzheimer's disease, could single-handedly account for 1% of all healthcare spending by next year. The Food and Drug Administration okayed the controversial drug on June 7 to treat Alzheimer's disease, which affects in the...